Related Experiment Videos

Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus

Shailesh Nandish1, Jamison Wyatt, Oscar Bailon

  • 1Division of Cardiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229, USA.

The American Journal of Cardiology
|August 2, 2011
PubMed

Insights

Cardiovascular risk reduction is crucial for patients with diabetes mellitus due to accelerated atherosclerosis. This review covers risk assessment tools and emerging biomarkers for preventing cardiovascular events.

Area of Science:

  • Cardiology
  • Endocrinology
  • Preventive Medicine

Background:

  • Diabetes mellitus accelerates atherosclerosis via hyperglycemia, endothelial dysfunction, and arterial changes.
  • Identifying reliable cardiovascular biomarkers is crucial for early detection of subclinical cardiovascular disease.
  • Current risk assessment tools need enhancement for diabetic patients.

Purpose of the Study:

  • To review current cardiovascular risk assessment tools in diabetes mellitus.
  • To explore emerging biomarkers for detecting subclinical cardiovascular disease.
  • To discuss optimal revascularization and risk reduction strategies.

Main Methods:

  • Review of existing literature on cardiovascular risk in diabetes.
  • Analysis of commonly used risk assessment tools.
  • Evaluation of emerging biomarkers (coronary artery calcium, metabolomics, genomics).

Main Results:

  • Diabetes accelerates atherosclerosis through multiple pathways.
  • Emerging biomarkers offer potential for noninvasive detection of subclinical disease.
  • Optimal revascularization and risk reduction strategies are key.

Conclusions:

  • Comprehensive cardiovascular risk management is essential for diabetic patients.
  • Novel biomarkers and advanced imaging improve risk stratification.
  • Personalized strategies are needed to reduce cardiovascular events in diabetes.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...